_id
69171f3e3c536f8df23167e9
Ticker
TLIS
Name
Talis Biomedical Corp
Exchange
PINK
Address
1375 West Fulton Market, Chicago, IL, United States, 60607
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://talisbio.com
Description
Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.
Last Close
1.6
Volume
500
Current Price
1.6
Change
0
Last Updated
2025-12-04T14:12:20.980Z
Image
https://logo.clearbit.com/talisbio.com
Ipo Date
2021-02-12T00:00:00.000Z
Market Cap
2916512
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
1
Target Price
5
Strong Buy
0
Buy
0
Hold
0
Sell
0
Strong Sell
1
Current Quarter
2024-06-30
Revenue
0
Cost Of Revenue
84000
Gross Profit
-84000
Operating Expenses
8494000
Operating Income
-9578000
Interest Expense
-
Pretax Income
-8849000
Net Income
-8849000
Eps
-4.855626194152617
Dividends Per Share
-
Shares Outstanding
1822820
Income Tax Expense
-
EBITDA
-9494000
Operating Margin
-
Total Other Income Expense Net
729000
Cash
59867000
Short Term Investments
-
Receivables
0
Inventories
-
Total Current Assets
63601000
Property Plant Equipment
8332000
Total Assets
72699000
Payables
3790000
Short Term Debt
5846000
Long Term Debt
-
Total Liabilities
24073000
Equity
48626000
Depreciation
84000
Change In Working Capital
-4638000
Cash From Operations
-11330000
Capital Expenditures
0
Cash From Investing
84000
Cash From Financing
0
Net Change In Cash
-10470000
PE
-
PB
0.0599653518693703
ROE
-18.198083329905813
ROA
-12.172106906559925
FCF
-11330000
Fcf Percent
-
Piotroski FScore
0
Health Score
41
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
8
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2024-06-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
84000
Quarters > 0 > income Statement > gross Profit
-84000
Quarters > 0 > income Statement > operating Expenses
8494000
Quarters > 0 > income Statement > operating Income
-9578000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-8849000
Quarters > 0 > income Statement > net Income
-8849000
Quarters > 0 > income Statement > eps
-4.855626194152617
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1822422
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-9494000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
729000
Quarters > 0 > balance Sheet > cash
59867000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
0
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
63601000
Quarters > 0 > balance Sheet > property Plant Equipment
8332000
Quarters > 0 > balance Sheet > total Assets
72699000
Quarters > 0 > balance Sheet > payables
3790000
Quarters > 0 > balance Sheet > short Term Debt
5846000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
24073000
Quarters > 0 > balance Sheet > equity
48626000
Quarters > 0 > cash Flow > net Income
-8849000
Quarters > 0 > cash Flow > depreciation
84000
Quarters > 0 > cash Flow > change In Working Capital
-4638000
Quarters > 0 > cash Flow > cash From Operations
-11330000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
84000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-10470000
Quarters > 0 > ratios > PE
-4.855626194152617
Quarters > 0 > ratios > PB
0.0599653518693703
Quarters > 0 > ratios > ROE
-18.198083329905813
Quarters > 0 > ratios > ROA
-12.172106906559925
Quarters > 0 > ratios > FCF
-11330000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2024-03-31
Quarters > 1 > income Statement > revenue
73000
Quarters > 1 > income Statement > cost Of Revenue
268000
Quarters > 1 > income Statement > gross Profit
-195000
Quarters > 1 > income Statement > operating Expenses
8951000
Quarters > 1 > income Statement > operating Income
-9146000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-13035000
Quarters > 1 > income Statement > net Income
-13035000
Quarters > 1 > income Statement > eps
-7.154029801597102
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1822050
Quarters > 1 > income Statement > income Tax Expense
218724
Quarters > 1 > income Statement > EBITDA
-13855000
Quarters > 1 > income Statement > operating Margin
-12528.767123287671
Quarters > 1 > income Statement > total Other Income Expense Net
-3889000
Quarters > 1 > balance Sheet > cash
70337000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
6000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
71170000
Quarters > 1 > balance Sheet > property Plant Equipment
9782000
Quarters > 1 > balance Sheet > total Assets
82494000
Quarters > 1 > balance Sheet > payables
3619000
Quarters > 1 > balance Sheet > short Term Debt
5804000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
25810000
Quarters > 1 > balance Sheet > equity
56684000
Quarters > 1 > cash Flow > net Income
-13035000
Quarters > 1 > cash Flow > depreciation
262000
Quarters > 1 > cash Flow > change In Working Capital
371000
Quarters > 1 > cash Flow > cash From Operations
-6427000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
30000
Quarters > 1 > cash Flow > cash From Financing
2000
Quarters > 1 > cash Flow > net Change In Cash
-6395000
Quarters > 1 > ratios > PE
-7.154029801597102
Quarters > 1 > ratios > PB
0.051430385999576604
Quarters > 1 > ratios > ROE
-22.995907134288334
Quarters > 1 > ratios > ROA
-15.801149174485419
Quarters > 1 > ratios > FCF
-6427000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-88.04109589041096
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
151000
Quarters > 2 > income Statement > cost Of Revenue
622000
Quarters > 2 > income Statement > gross Profit
-471000
Quarters > 2 > income Statement > operating Expenses
14029000
Quarters > 2 > income Statement > operating Income
-14500000
Quarters > 2 > income Statement > interest Expense
1166000
Quarters > 2 > income Statement > pretax Income
-13460000
Quarters > 2 > income Statement > net Income
-13460000
Quarters > 2 > income Statement > eps
-6.371968640067564
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
2112377
Quarters > 2 > income Statement > income Tax Expense
1166000
Quarters > 2 > income Statement > EBITDA
-14289000
Quarters > 2 > income Statement > operating Margin
-9602.649006622516
Quarters > 2 > income Statement > total Other Income Expense Net
1040000
Quarters > 2 > balance Sheet > cash
76732000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
50000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
77683000
Quarters > 2 > balance Sheet > property Plant Equipment
15449000
Quarters > 2 > balance Sheet > total Assets
98340000
Quarters > 2 > balance Sheet > payables
1339000
Quarters > 2 > balance Sheet > short Term Debt
2882000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
29224000
Quarters > 2 > balance Sheet > equity
69116000
Quarters > 2 > cash Flow > net Income
-13460000
Quarters > 2 > cash Flow > depreciation
614000
Quarters > 2 > cash Flow > change In Working Capital
469000
Quarters > 2 > cash Flow > cash From Operations
-11357000
Quarters > 2 > cash Flow > capital Expenditures
93000
Quarters > 2 > cash Flow > cash From Investing
93000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-11264000
Quarters > 2 > ratios > PE
-6.371968640067564
Quarters > 2 > ratios > PB
0.04890044562764049
Quarters > 2 > ratios > ROE
-19.474506626540887
Quarters > 2 > ratios > ROA
-13.68720764693919
Quarters > 2 > ratios > FCF
-11450000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-75.82781456953643
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2023-09-30
Quarters > 3 > income Statement > revenue
76000
Quarters > 3 > income Statement > cost Of Revenue
6000
Quarters > 3 > income Statement > gross Profit
70000
Quarters > 3 > income Statement > operating Expenses
17041000
Quarters > 3 > income Statement > operating Income
-16971000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-15682000
Quarters > 3 > income Statement > net Income
-15682000
Quarters > 3 > income Statement > eps
-8.620907652608537
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1819066
Quarters > 3 > income Statement > income Tax Expense
256586
Quarters > 3 > income Statement > EBITDA
-16377000
Quarters > 3 > income Statement > operating Margin
-22330.263157894737
Quarters > 3 > income Statement > total Other Income Expense Net
1289000
Quarters > 3 > balance Sheet > cash
87996000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
5000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
89532000
Quarters > 3 > balance Sheet > property Plant Equipment
16154000
Quarters > 3 > balance Sheet > total Assets
107228000
Quarters > 3 > balance Sheet > payables
2697000
Quarters > 3 > balance Sheet > short Term Debt
2861000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
25672000
Quarters > 3 > balance Sheet > equity
81556000
Quarters > 3 > cash Flow > net Income
-15682000
Quarters > 3 > cash Flow > depreciation
217000
Quarters > 3 > cash Flow > change In Working Capital
42000
Quarters > 3 > cash Flow > cash From Operations
-11144000
Quarters > 3 > cash Flow > capital Expenditures
70000
Quarters > 3 > cash Flow > cash From Investing
-70000
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-11214000
Quarters > 3 > ratios > PE
-8.620907652608537
Quarters > 3 > ratios > PB
0.0356872038844475
Quarters > 3 > ratios > ROE
-19.228505566727158
Quarters > 3 > ratios > ROA
-14.624911403737832
Quarters > 3 > ratios > FCF
-11214000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-147.55263157894737
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
412000
Annuals > 0 > income Statement > cost Of Revenue
41000
Annuals > 0 > income Statement > gross Profit
371000
Annuals > 0 > income Statement > operating Expenses
67186000
Annuals > 0 > income Statement > operating Income
-66815000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-62007000
Annuals > 0 > income Statement > net Income
-62007000
Annuals > 0 > income Statement > eps
-34.116531114615306
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1817506
Annuals > 0 > income Statement > income Tax Expense
4906105
Annuals > 0 > income Statement > EBITDA
-66045000
Annuals > 0 > income Statement > operating Margin
-16217.233009708738
Annuals > 0 > income Statement > total Other Income Expense Net
4808000
Annuals > 0 > balance Sheet > cash
76732000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
50000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
77683000
Annuals > 0 > balance Sheet > property Plant Equipment
15449000
Annuals > 0 > balance Sheet > total Assets
94674000
Annuals > 0 > balance Sheet > payables
1339000
Annuals > 0 > balance Sheet > short Term Debt
2882000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
25558000
Annuals > 0 > balance Sheet > equity
69116000
Annuals > 0 > cash Flow > net Income
-62007000
Annuals > 0 > cash Flow > depreciation
770000
Annuals > 0 > cash Flow > change In Working Capital
-3424000
Annuals > 0 > cash Flow > cash From Operations
-53240000
Annuals > 0 > cash Flow > capital Expenditures
486000
Annuals > 0 > cash Flow > cash From Investing
-486000
Annuals > 0 > cash Flow > cash From Financing
33000
Annuals > 0 > cash Flow > net Change In Cash
-53693000
Annuals > 0 > ratios > PE
-34.116531114615306
Annuals > 0 > ratios > PB
0.04207433300538226
Annuals > 0 > ratios > ROE
-89.71439319405057
Annuals > 0 > ratios > ROA
-65.4952785347614
Annuals > 0 > ratios > FCF
-53726000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-130.40291262135923
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
3652000
Annuals > 1 > income Statement > cost Of Revenue
8391000
Annuals > 1 > income Statement > gross Profit
-4739000
Annuals > 1 > income Statement > operating Expenses
110400000
Annuals > 1 > income Statement > operating Income
-115139000
Annuals > 1 > income Statement > interest Expense
2127000
Annuals > 1 > income Statement > pretax Income
-113012000
Annuals > 1 > income Statement > net Income
-110885000
Annuals > 1 > income Statement > eps
-62.4511066717956
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
1775549
Annuals > 1 > income Statement > income Tax Expense
-2127000
Annuals > 1 > income Statement > EBITDA
-106309000
Annuals > 1 > income Statement > operating Margin
-3152.7656078860896
Annuals > 1 > income Statement > total Other Income Expense Net
2127000
Annuals > 1 > balance Sheet > cash
130191000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
308000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
133282000
Annuals > 1 > balance Sheet > property Plant Equipment
34232000
Annuals > 1 > balance Sheet > total Assets
169290000
Annuals > 1 > balance Sheet > payables
3768000
Annuals > 1 > balance Sheet > short Term Debt
3703000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
42551000
Annuals > 1 > balance Sheet > equity
126739000
Annuals > 1 > cash Flow > net Income
-113012000
Annuals > 1 > cash Flow > depreciation
8830000
Annuals > 1 > cash Flow > change In Working Capital
-7686000
Annuals > 1 > cash Flow > cash From Operations
-100136000
Annuals > 1 > cash Flow > capital Expenditures
1615000
Annuals > 1 > cash Flow > cash From Investing
-1615000
Annuals > 1 > cash Flow > cash From Financing
406000
Annuals > 1 > cash Flow > net Change In Cash
-101345000
Annuals > 1 > ratios > PE
-62.4511066717956
Annuals > 1 > ratios > PB
0.022415187116830652
Annuals > 1 > ratios > ROE
-87.49082760634059
Annuals > 1 > ratios > ROA
-65.50002953511725
Annuals > 1 > ratios > FCF
-101751000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-27.86171960569551
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
8.19
Annuals > 2 > income Statement > cost Of Revenue
2621000
Annuals > 2 > income Statement > gross Profit
-2621000
Annuals > 2 > income Statement > operating Expenses
191816000
Annuals > 2 > income Statement > operating Income
-191816000
Annuals > 2 > income Statement > interest Expense
1358000
Annuals > 2 > income Statement > pretax Income
-192036000
Annuals > 2 > income Statement > net Income
-190458000
Annuals > 2 > income Statement > eps
-126.13112582781457
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
1510000
Annuals > 2 > income Statement > income Tax Expense
-1578000
Annuals > 2 > income Statement > EBITDA
-190238000
Annuals > 2 > income Statement > operating Margin
-2342075702.075702
Annuals > 2 > income Statement > total Other Income Expense Net
-220000
Annuals > 2 > balance Sheet > cash
232545000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
183000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
236115000
Annuals > 2 > balance Sheet > property Plant Equipment
23435000
Annuals > 2 > balance Sheet > total Assets
265828000
Annuals > 2 > balance Sheet > payables
5122000
Annuals > 2 > balance Sheet > short Term Debt
2464000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
31851000
Annuals > 2 > balance Sheet > equity
233977000
Annuals > 2 > cash Flow > net Income
-192036000
Annuals > 2 > cash Flow > depreciation
1578000
Annuals > 2 > cash Flow > change In Working Capital
8824000
Annuals > 2 > cash Flow > cash From Operations
-171384000
Annuals > 2 > cash Flow > capital Expenditures
2866000
Annuals > 2 > cash Flow > cash From Investing
-2866000
Annuals > 2 > cash Flow > cash From Financing
234429000
Annuals > 2 > cash Flow > net Change In Cash
60179000
Annuals > 2 > ratios > PE
-126.13112582781457
Annuals > 2 > ratios > PB
0.010325801253969407
Annuals > 2 > ratios > ROE
-81.40030857733879
Annuals > 2 > ratios > ROA
-71.64708006681012
Annuals > 2 > ratios > FCF
-174250000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-21275946.275946278
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
10938000
Annuals > 3 > income Statement > cost Of Revenue
1374000
Annuals > 3 > income Statement > gross Profit
9564000
Annuals > 3 > income Statement > operating Expenses
100748000
Annuals > 3 > income Statement > operating Income
-91184000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-91130000
Annuals > 3 > income Statement > net Income
-91076000
Annuals > 3 > income Statement > eps
-314.0551724137931
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
290000
Annuals > 3 > income Statement > income Tax Expense
-54000
Annuals > 3 > income Statement > EBITDA
-89756000
Annuals > 3 > income Statement > operating Margin
-833.6441762662279
Annuals > 3 > income Statement > total Other Income Expense Net
54000
Annuals > 3 > balance Sheet > cash
138483000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
471000
Annuals > 3 > balance Sheet > inventories
46664000
Annuals > 3 > balance Sheet > total Current Assets
188724000
Annuals > 3 > balance Sheet > property Plant Equipment
9681000
Annuals > 3 > balance Sheet > total Assets
198405000
Annuals > 3 > balance Sheet > payables
4906000
Annuals > 3 > balance Sheet > short Term Debt
1386000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
306976000
Annuals > 3 > balance Sheet > equity
-108571000
Annuals > 3 > cash Flow > net Income
-91130000
Annuals > 3 > cash Flow > depreciation
763000
Annuals > 3 > cash Flow > change In Working Capital
-951000
Annuals > 3 > cash Flow > cash From Operations
-87024000
Annuals > 3 > cash Flow > capital Expenditures
8201000
Annuals > 3 > cash Flow > cash From Investing
-8201000
Annuals > 3 > cash Flow > cash From Financing
246754000
Annuals > 3 > cash Flow > net Change In Cash
151529000
Annuals > 3 > ratios > PE
-314.0551724137931
Annuals > 3 > ratios > PB
-0.004273701080399002
Annuals > 3 > ratios > ROE
83.88612060310764
Annuals > 3 > ratios > ROA
-45.90408507850105
Annuals > 3 > ratios > FCF
-95225000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-8.70588773084659
Annuals > 3 > health Score
30
Valuation > metrics > PE
-4.855626194152617
Valuation > metrics > PB
0.0599653518693703
Valuation > final Score
70
Valuation > verdict
94.0% Undervalued
Profitability > metrics > ROE
-18.198083329905813
Profitability > metrics > ROA
-13.9133032499489
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4950643688561675
Risk > metrics > Interest Coverage
-14.849612403100775
Risk > final Score
1
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.600352843503528
Liquidity > metrics > Quick Ratio
6.600352843503528
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
15
Prev Risks > 1
10
Prev Risks > 2
-38
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:18:34.003Z
Earnings History > 0 > period
2024-06-30
Earnings History > 0 > report Date
2024-08-13
Earnings History > 0 > date
2024-06-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-4.8556
Earnings History > 0 > eps Estimate
-5.91
Earnings History > 0 > eps Difference
1.0544
Earnings History > 0 > surprise Percent
17.8409
Earnings History > 1 > period
2024-03-31
Earnings History > 1 > report Date
2024-05-08
Earnings History > 1 > date
2024-03-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-7.154
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2023-12-31
Earnings History > 2 > report Date
2024-03-28
Earnings History > 2 > date
2023-12-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.4248
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-09-30
Earnings History > 3 > report Date
2023-11-14
Earnings History > 3 > date
2023-09-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-8.6209
Earnings History > 3 > eps Estimate
-0.6196
Earnings History > 3 > eps Difference
-8.0013
Earnings History > 3 > surprise Percent
-1291.3654
Earnings History > 4 > period
2023-06-30
Earnings History > 4 > report Date
2023-08-10
Earnings History > 4 > date
2023-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-8.27
Earnings History > 4 > eps Estimate
-0.73
Earnings History > 4 > eps Difference
-7.54
Earnings History > 4 > surprise Percent
-1032.8767
Earnings History > 5 > period
2023-03-31
Earnings History > 5 > report Date
2023-05-11
Earnings History > 5 > date
2023-03-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.6915
Earnings History > 5 > eps Estimate
-0.73
Earnings History > 5 > eps Difference
0.0385
Earnings History > 5 > surprise Percent
5.274
Earnings History > 6 > period
2022-12-31
Earnings History > 6 > report Date
2023-03-22
Earnings History > 6 > date
2022-12-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1
Earnings History > 6 > eps Estimate
-0.68
Earnings History > 6 > eps Difference
-0.32
Earnings History > 6 > surprise Percent
-47.0588
Earnings History > 7 > period
2022-09-30
Earnings History > 7 > report Date
2022-11-03
Earnings History > 7 > date
2022-09-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.98
Earnings History > 7 > eps Estimate
-0.78
Earnings History > 7 > eps Difference
-0.2
Earnings History > 7 > surprise Percent
-25.641
Earnings History > 8 > period
2022-06-30
Earnings History > 8 > report Date
2022-08-02
Earnings History > 8 > date
2022-06-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.01
Earnings History > 8 > eps Estimate
-0.8
Earnings History > 8 > eps Difference
-0.21
Earnings History > 8 > surprise Percent
-26.25
Earnings History > 9 > period
2022-03-31
Earnings History > 9 > report Date
2022-05-10
Earnings History > 9 > date
2022-03-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.25
Earnings History > 9 > eps Estimate
-1.18
Earnings History > 9 > eps Difference
-0.07
Earnings History > 9 > surprise Percent
-5.9322
Earnings History > 10 > period
2021-12-31
Earnings History > 10 > report Date
2022-03-15
Earnings History > 10 > date
2021-12-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1.26
Earnings History > 10 > eps Estimate
-1.28
Earnings History > 10 > eps Difference
0.02
Earnings History > 10 > surprise Percent
1.5625
Earnings History > 11 > period
2021-09-30
Earnings History > 11 > report Date
2021-11-15
Earnings History > 11 > date
2021-09-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-1.49
Earnings History > 11 > eps Estimate
-1.4
Earnings History > 11 > eps Difference
-0.09
Earnings History > 11 > surprise Percent
-6.4286
Earnings History > 12 > period
2021-06-30
Earnings History > 12 > report Date
2021-08-10
Earnings History > 12 > date
2021-06-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-2.51
Earnings History > 12 > eps Estimate
-0.91
Earnings History > 12 > eps Difference
-1.6
Earnings History > 12 > surprise Percent
-175.8242
Earnings History > 13 > period
2021-03-31
Earnings History > 13 > report Date
2021-05-13
Earnings History > 13 > date
2021-03-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-4.61
Earnings History > 13 > eps Estimate
-0.75
Earnings History > 13 > eps Difference
-3.86
Earnings History > 13 > surprise Percent
-514.6667
Earnings History > 14 > period
2020-12-31
Earnings History > 14 > report Date
2021-03-30
Earnings History > 14 > date
2020-12-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-20.84
Earnings History > 14 > eps Estimate
-0.78
Earnings History > 14 > eps Difference
-20.06
Earnings History > 14 > surprise Percent
-2571.7949
Earnings History > 15 > period
2020-09-30
Earnings History > 15 > report Date
2020-12-02
Earnings History > 15 > date
2020-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-8.1
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-8.1
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2019-09-30
Earnings History > 16 > report Date
2019-12-31
Earnings History > 16 > date
2019-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.7601
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.7601
Earnings History > 16 > surprise Percent
-
Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AStock market holidays 2026: NSE releases full list, stock market to remain shut for 15 days — check details MSN
Read more →Stock market holidays 2026: NSE releases full list, stock market to remain shut for 15 days — check details livemint.com
Read more →Showing 2 of 10
(Last Updated 2024-06-30)
Rating:
STRONG SELL
Target Price:
$5
Analyst Picks
Strong Buy
0
Buy
0
Hold
0
Sell
0
Strong Sell
1
(Last Updated 2024-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 16.22% of the total shares of Talis Biomedical Corp
1.
BML Capital Management LLC(13.6438%)
since
2024/09/30
2.
Springbok Capital Management, LLC(0.819%)
since
2024/06/30
3.
Geode Capital Management, LLC(0.7691%)
since
2024/06/30
4.
Susquehanna International Group, LLP(0.6368%)
since
2024/06/30
5.
BlackRock Inc(0.2343%)
since
2024/06/30
6.
Tower Research Capital LLC(0.0481%)
since
2024/06/30
7.
BlackRock Event Driven Equity Instl(0.0308%)
since
2024/09/30
8.
Morgan Stanley - Brokerage Accounts(0.0095%)
since
2024/06/30
9.
SSgA U.S. Total Market Index Strategy(0.0092%)
since
2024/06/30
10.
Steward Partners Investment Advisory, LLC(0.0081%)
since
2024/06/30
11.
Advisor Group Holdings, Inc.(0.0046%)
since
2024/06/30
12.
Larson Financial Group, LLC(0.0008%)
since
2024/06/30
13.
Bank of America Corp(0.0007%)
since
2024/06/30
14.
UBS Group AG(0.0006%)
since
2024/06/30
15.
Guggenheim Active Allocation Fund(0.0003%)
since
2024/08/31
16.
JPMorgan Chase & Co(0.0002%)
since
2024/06/30
17.
Qube Research & Technologies(0.0001%)
since
2024/06/30
18.
ADAR1 Capital Management LLC(0%)
since
2024/06/30
19.
Wells Fargo & Co(0%)
since
2024/06/30
20.
Baker Bros Advisors LP(0%)
since
2024/09/30
21.
Renaissance Technologies Corp(0%)
since
2024/09/30
22.
Vanguard Group Inc(0%)
since
2024/09/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-06-30
EPS Actual
-4.8556
EPS Estimate
-5.91
EPS Difference
1.0544
Surprise Percent
17.8409%
(Last Updated 2024-06-30)
(Last Updated 2024-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2024-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.